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Abstract. A subsynaptic protein of M X300 kD is a
major component of Torpedo electric organ postsynap-
tic membranes and copurifies with the AChR and the
43-kD subsynaptic protein. mAbs against this protein
react with neuromuscular synapses in higher verte-
brates, but not at synapses in dystrophic muscle. The
Torpedo 300-kD protein comigrates in SDS-PAGE with
murine dystrophin and reacts with antibodies against
murine dystrophin. The sequence of a partial cDNA
M
UTATIONS in the gene encoding dystrophin can re-
sult in myopathies termed Duchenne or Becker
muscular dystrophy (Koenig et al., 1989) . Dystro-
phin expression is restricted to muscle and nervous tissue,
and in skeletal muscle, the protein is found at the intracellu-
lar surface of the nonsynaptic plasma membrane (Watkins et
al., 1988; Zubrzycka-Gaam et al., 1988 ; Bonilla et al.,
1988; Sugita et al., 1988). It is not clear how loss of dystro-
phin results in myopathies.
Recent studies have demonstrated that antibodies against
dystrophin cross-react with a protein enriched at neuromus-
cular synapses (Chang et al ., 1989; Jasmin et al., 1990; Far-
deau et al., 1990) . However, because antibodies against dys-
trophin can cross-react with other proteins that contain
homologous domains (Hoffman et al., 1989), it is difficult
to ascertain whether the cross-reacting molecule at the syn-
apse is dystrophin rather than another molecule which shares
epitopes with dystrophin. Indeed, a recent study has shown
that dystrophin-like immunoreactivity persists at synaptic
sites in dystrophic muscle (Fardeau et al., 1990). In this
study we provide strong evidence that dystrophin itself is
present at synaptic sites.
We have shown previously that a peripheral membrane
protein of M -300 kD copurifies with postsynaptic mem-
branes isolated from Torpedo electric organand appears con-
centrated at neuromuscular synapses (Burden et al., 1983;
Woodruff et al ., 1987) . We have now isolated a cDNA by
screening an expression library with mAbs against the
Torpedo 300-kD protein, and show that the amino acid se-
quence encoded by this partial cDNA is homologous to dys-
trophin. The cDNA encodes a protein with repeat units that
have 60-70% amino acid sequence identity with the repeat
units in human dystrophin and a carboxy-terminal region
with 90% homology to the dystrophin b isoform . Moreover,
antibodies against murine dystrophin react with a Torpedo
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isolated by screening an expression library with mAbs
against the Torpedo 300-kD protein shows striking ho-
mology to mammalian dystrophin, and in particular to
the b isoform of dystrophin. These results indicate that
dystrophin is a component of the postsynaptic mem
brane at neuromuscular synapses and raise the possibil-
ity that loss of dystrophin from synapses in dystrophic
muscle may have consequences that contribute to mus-
cular dystrophy.
300-kD protein, which comigrates in SDS-PAGE with mu-
rine dystrophin, and mAbs against the Torpedo 300-kD pro-
tein react with neuromuscular synapses in normal, but not
dystrophic, mouse muscle. These results provide strong evi-
dence that dystrophin is present at neuromuscular synapses
and raise the possibility that the absence of dystrophin from
synapses in dystrophic muscle may perturb the structure
and/or function of the synapse and contribute to muscular
dystrophy.
Materials andMethods
IsolationofAChR-rich Membranesand
Western Blotting
AChR-rich and AChR-poor membranes were isolated from Torpedoelectric
organ as described previously (Burden et al., 1983). The M, of 300-kD
protein was determined in 6% polyacrylamide SDS gels with human eryth-
rocyte spectrin and rabbit macrophage actin-binding protein as molecular
weight standards (Woodruffet al., 1987). Peripheral proteins from AChR-
rich membranes were fractionated by two-dimensional gels as described
previously (Burden, 1985). Western blots were probed with mAb hybrid-
oma supernatant, affinity-purified antibodies against a trpE+60 kD mouse
dystrophin fusion protein (encoding the first four repeats in murine dystro-
phin; Hoffman et al., 1987) diluted 1:2,000, and affinity-purified antibodies
against a trpE fusion protein containing the carboxy-terminal region of hu-
man dystrophin (antibody 11; Koenig and Kunkel, 1990) diluted 1:500, fol-
lowed by alkaline phosphatase-coupled secondary antibodies.
Immunohistochemistry
Staining of unfixed frozen sections from Torpedo electric organ was per-
formed as described previously (Woodruff et al., 1987) . Affinity-purified
antibodies against a trpE+60-kD murine dystrophin fusion protein dystro-
phin (Hoffman et al., 1987) were used at 1:2,000, and hybridoma superna-
tant containing mAb 602 was used undiluted. Frozen sections (8,urn) from
unfixed intercostal muscles were stained with biotinylated mAb 601 (identi-
cal results were obtained with a different mAb against the Torpedo300-kD
protein, mAb 607) or with antibodies against the trpE+60-kD dystrophinfusion protein (Hoffman, et al ., 1987) diluted 1:2,000 for 1 h at room tem-
perature. After incubation with eitherfluorescein-labeled avidin or fluores-
cein-labeled goat-anti-sheep IgG and TMR-BGT, sections were visualized
with optics selective for either rhodamine or fluorescein (Woodruff et al .,
1987) .
Rat myotubes were fixed (1% paraformaldehyde in PBS) for 15 min,
washed (in PBS), permeabilized with 0.1% NP-40 (in PBS), incubated with
hybridoma supernatant containing mAb 601 (2 h at room temperature) and
subsequently with fluorescein-labeled goat-anti-mouse IgG and TMR-
BGT. AChR clusters inthe murine C2 muscle cell line arelabeled withmAb
601 as well (J. A . Theriot and S. J. Burden, unpublished results) .
Molecular BiologicalMethods
300,000 recombinant phage from a agtll Torpedo electric organ cDNA li-
brary (Baldwin et al ., 1988a) were screened with four different mAbs (601,
602, 603, 604) that react exclusively with the Torpedo electric organ 300-
kD protein (Woodruff et al ., 1987) . One positive phage was detected with
mAb 602, which identified a phage harboring a 4.1-kb cDNA insert . Our
other mAbs against the Torpedo 300-kD protein do not react with the fusion
protein, and these antibodies presumably react with regions ofTorpedodys-
trophin that are not encoded by thepartial cDNA . Affinity-purified antibod-
ies against the carboxy-terminal region of human dystrophin (antibody 10 ;
Koenig and Kunkel, 1990) also react with the fusion protein and with the
Torpedo 300-kD protein (data not presented) . cDNA from the purified
phage was mapped with restriction endonucleases and sequenced (Sanger
et al ., 1977; Baldwin et al ., 19886) . ThecDNA clone encodes an additional
The Journal of Cell Biology, Volume 115, 1991
￿
1070
x+1.5 kb beyond the termination codon and ends with a 44-bp poly A tract,
which presumably represents the 3' end ofthe mRNA. The deduced amino
acid sequences of Torpedo 300-kD protein and human dystrophin were
aligned (Wilbur and Lipmann, 1983) .
An additional seven cDNAs have been detected by screening 80,000
recombinant phage with a920-bp probe derived from the 4.1-kbcDNA (hy-
bridization in 5x SSC, 50°C, washed in 0.2x SSC, 56°C) (Ravin et al .,
1991) . Thus, the relative abundance of cDNAs in this library encoding dys-
trophin (0.9:10,000), 43-kD protein (4 .5:10,000) (Baldwin et al ., 1988a)
and AChR alpha subunit (11/10,000) (Baldwin et al., 19886) is similar to
the relative abundance ofthecorresponding proteins (1:10:20 ; Burden et al .,
1983) .
"P-labeled, random-primed probe derived from the 4.1-kb cDNA en-
coding the Torpedo 300-kD protein was hybridized to a Northern blot of
totalRNA (301~g per lane) isolated from Torpedo electric organ . The blot
was hybridized overnight (in 5x SSPE) at 55°C and washed (in 0.2X SSC,
0.1% SDS) at 57°C (Baldwin et al ., 19886) . An RNA ladder of 9.5, 7.5,
4.4, 2.4, 1 .4, 0.2 kb was used to estimate the size ofthe Torpedo transcript .
Results
The Torpedo300-kD Protein andDystrophin
ShareEpitopes
Antibodies against the first four repeats in murine dystrophin
react with a protein concentrated in AChR-rich membranes
Figure 1. Antibodies against dystrophin cross-react with the Torpedo300 kD subsynaptic protein, which copurifies with AChR-rich mem-
branes . (a) Postsynaptic membranes from Torpedo electric organ were fractionated in an equilibrium density sucrose gradient and the pro-
tein composition was analyzed by SDS-PAGE . Proteins inAM-rich (R) and AChR-poor (P) membranes were fractionated by SDS-PAGE
(6% polyacrylamide) and either stained with Coomassie brilliant blue or transferred to nitrocellulose and probed with mAb (602) to the
Torpedo 300AD protein or antibodies to murine dystrophin (trpE+60 kD) . Both antibodies react with the 300-kD protein (arrowhead),
which is more abundant in AChR-rich than in AChR-poor membranes . Labeling of the protein band just beneath the 300AD protein with
mAbs against the300AD protein is variable, and is likely due to partial proteolysis of the 300AD protein . Antibodies against dystrophin,
but not mAbs against the Torpedo 300AD protein, react with several proteins (*) that are enriched in AChR-poor membrane fractions
and are thus not likely to be proteolytic fragments ofdystrophin ; these proteins are not labeled with secondary antibody alone, and therefore
cross-react with the antibodies against murine dystrophin . (b) Peripheral membrane proteins from AChR-rich were resolved by two-
dimensional electrophoresis, transferred to nitrocellulose, and probed either with mAb (602) tothe Torpedo300AD protein or with affinity-
purified antibodies to the carboxy-terminal region of human dystrophin (antibody 11) . The different antibodies react with the same protein,
since the 300AD protein (arrowhead) as well as the same set of proteolytic fragments are labeled with both antibodies . The basic (B)
and acidic (A) directions are indicated . (c) The innervated surface of the Torpedo electrocyte is labeled with mAbs against the Torpedo
300-kD protein and antibodies against dystrophin . Single frozen sections of Torpedoelectric organ were labeled with tetramethylrhodamine-
labeled «-bungarotoxin (BGT) (b, d, and f) and with either mAb 602 (a), antibodies against dystrophin (c), or mAb against a Torpedo
intermediate filament protein (e) (Burden, 1982) . The magnification is 400x .isolated from Torpedo electric organ (Fig . 1 a) . The cross-
reacting protein comigrates in SDS-PAGE with the 300-kD
subsynaptic protein that we identified previously as a compo-
nent ofthe postsynaptic membrane in Torpedo electric organ
and in skeletal myofibers (Fig . 1 a) (Burden et al ., 1983 ;
Woodruff et al ., 1987) .
Because several proteins could comigrate at 300-kD, pro-
teins from AChR-rich membranes were resolved further by
IEF, and blots from two dimensional gels were probed either
with antibodies against human dystrophin or with a mAb
against the Torpedo 300-kD protein . Fig. 1 b shows that the
different antibodies react with the same protein, since the
300-kD protein as well as the same set of proteolytic frag-
ments are labeled with both antibodies . Thus, antibodies
against dystrophin react with the 300-kD protein that we
identified previously.
Furthermore, all of ourmAbs against the 300-kD protein
(Woodruff et al ., 1987), and antibodies against murine dys-
trophin (Hoffman et al ., 1987), react in situ with the post-
synaptic membrane of the electrocyte (Fig . 1 c ; see also
Chang et al ., 1989) .
mAbs Against the Torpedo 300-kD Protein
React with Synaptic Sites in Normal, but Not
Dystrophic, Muscle
Among themAbs that we produced against the Torpedo 300-
kD protein, mAb 601 cross-reacts with neuromuscular syn-
apses in both amphibian and mammalian muscle (Woodruff
et al ., 1987) . We used mAb 601 to determine whether the
molecule recognized by this antibody is absent from synaptic
sites in dystrophic (mdx) mouse muscle (Bulfield et al .,
1984) . Fig . 2 demonstrates that mAb 601 reacts with synap-
tic sites in normal, but not in dystrophic, mouse muscle . Ex-
trasynaptic staining is also detectable with mAb 601 in nor-
mal, but not dystrophic, mouse muscle (Fig . 2) . In addition,
antibodies against murine dystrophin react with synaptic
sites in normal (Fig . 2 ; see also Chang et al ., 1989), but not
dystrophic, muscle (Fig . 2) . Thus, a protein in normal mouse
muscle that reacts with mAb 601 is absent from dystrophic
muscle .
The protein product of an autosomal gene has homology
to the product of the X-linked dystrophin gene (Love et al.,
1989), and this protein has been termed dystrophin-related
protein (DRP)' (Khurana et al., 1990) . However, since
DRP is retained in muscle from mdx mice (Khurana et al.,
1990), neither mAb 601 nor the antibodies against murine
dystrophin used in this study react with DRP
Clusters of AChRs occur at synaptic sites in innervated
skeletal muscle and can also form in the absence of innerva-
tion in cultured embryonic myotubes (Vogel et al ., 1972 ;
Fischbach and Cohen, 1973) . We examined whether the
molecule recognized by mAb 601 is concentrated at AChR
clusters in myotube cultures as well as at synaptic sites . Fig .
3 demonstrates thatmAb 601 staining is present throughout
the myotube, but is concentrated at AChR clusters . More-
over, there is an intricate arrangement of AChRs within a
cluster, and a similar, but not identical, arrangement is seen
with mAb 601 (see also Sealock et al ., 1991) . SincemAb 601
reactivity is concentrated at AChR clusters in noninnervated
1 . Abbreviations used in this paper : AchR, acetylcholine receptor ; DRP,
dystrophin-related protein .
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Figure 2 . Both antibodies against murine dystrophin and rnAb
against the Torpedo 300-kD protein label synaptic sites in normal,
but not in dystrophic, mouse muscle. Frozen sections of normal
(a-d) and mdx (e-h) mouse muscle were labeled with biotinylated
mAb 601 (a and e), or to dystrophin antibodies (c and g), followed
by appropriate fluorescein-labeled secondary reagents and TMR-
BGT (b, d, f, and h) . We have not investigated whether the number
or size of endplates is altered in mdx muscle . Bar, 20 tLm .
embryonic myotubes and at synapses in newborn rats (data
not presented), the association of the 300-kD subsynaptic
protein with the postsynaptic membrane is likely to be an
early event during synaptogenesis. Furthermore, since fold-
ing of the plasma membrane at AChR clusters in cultured
myotubes is rare (Vogel and Daniels, 1976), the accumula-
tion of the 300-kD protein at these sites cannot be attributed
entirely to an increase in membrane folding .
Dystrophin and the Torpedo 300-kDprotein
In our previous studies we used SDS-PAGE to estimate an
M, of 300 kD for the Torpedo electric organ subsynaptic
protein (Woodruff et al ., 1987) . The molecular mass ofhu-
man dystrophin, calculated from the amino sequence
deduced from cDNA, is 427 kD (Koenig et al., 1988) . Fig.
4 demonstrates that the Torpedo electric organ 300-kD pro-
tein and murine dystrophin comigrate in SDS-PAGE, since
antibodies against murine dystrophin react with a protein of
107 1identical size in Torpedo AChR-rich membranes and in nor-
mal, but not mdx, mouse muscle.
Dystrophin is composed of 24 repeats (Koenig and
Kunkel, 1990), which have structural similarity to repeats in
spectrin and a-actinin (Davison and Critchley, 1988 ; Ham-
mond, 1987 ; Koenig et al., 1988) . Each repeat is thought to
be organized into three alpha helixes which form coil-coil
interactions, and this common structural feature can be de-
tected with antibodies raised against dystrophin, which can
cross-react with a-actinin (Hoffman et al., 1989) . Thus, we
were concerned that antibodies against dystrophin could
cross-react with other proteins that share these repeats (see
also Fig . 1 b) . Antibodies against a-actinin (Bloch and Hall,
1983) and a-spectrin (Bloch and Morrow, 1989), as well as
antibodies against dystrophin (Fig . 2 ; see also Chang et al.,
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Figure 4. The Torpedo 300-kD pro-
tein and murine dystrophin comigrate in
SDS-PAGE . Proteins from Torpedo elec-
tric organ AChR-rich membranes and
total protein (ti70 jAg) from normal and
mdx mouse muscle were fractionated by
SDS-PAGE (6% polyacrylamide), trans-
ferred to nitrocellulose, and probed with
antibodies to murine dystrophin (trpE+
60kD ; Hoffman et al ., 1987) . The Tor-
pedo electric organ 300-kD protein and
murine dystrophin comigrate in SDS-
PAGE (arrowhead), since antibodies
against murine dystrophin react with a
protein of identical size in Torpedo
AChR-rich membranes (R) and in nor-
mal (nor), but not mdx (mdx) mouse
muscle. Labelingof skeletal muscle pro-
tein(s) that migrate more slowly than
dystrophin is nonspecific, since label-
ing is detected with secondary antibody
alone ; however, the antibodies to dystro-
phin cross-react weakly with myosin
(arrow), which is present at similar lev-
els in normal and mdx muscle .
Figure 3. AChR clusters in primary
rat myotubes are labeled with mAb
against the'Torpedo 300-kD protein .
Rat myotubes were labeled withmAb
601 (a and c), followed by fluo-
rescein-labeled goat-anti-mouse IgG
andTMR-BGT (b and d) . Antibody
labeling is present throughout the
myofiber, but is concentrated atAChR
clusters . WithinAChR clusters, a sim-
ilar pattern of labeling is seen with
TMR-BGTandmAb601 . Bar, 10 /,m .
1989), react with synaptic sites in skeletal muscle ; however,
identification of the molecule(s) recognized by these anti-
bodies is complicated by the possibility of cross-reactivity
due to the conserved structural feature described above .
Although the lack of reactivity of mAb 601 in dystrophic
muscle strongly suggests that the antibody recognizes dys-
trophin, it remains possible, however, that the mAb cross-
reacts with another molecule whose loss is an indirect conse-
quence of the absence of dystrophin . Indeed, it is clear that
other proteins, in addition to dystrophin, are absent from
skeletal muscle in the mdx mouse (Ervasti et al ., 1990) and
in individuals with Duchenne muscular dystrophy (Hoffman
et al ., 1987) . Thus, we sought an additional and different
method to establish a relationship between dystrophin and
the 300-kD subsynaptic protein .
The Sequence ofa Torpedo Electric Organ cDNA Is
Homologous to Dystrophin
We usedmAbs against the Torpedo 300-kD subsynaptic pro-
tein to screen an expression library from Torpedo electric or-
gan . We isolated a cDNA that encodes a protein that reacts
with one of these mAbs (602), and the protein-coding por-
tion of thiscDNA was sequenced . Figs . 5 and 6 demonstrate
that the amino acid sequence deduced from the Torpedo
cDNA, is strikingly homologous tohuman dystrophin . Fur-
thermore, affinity-purified antibodies against the carboxy-
terminal region of human dystrophin (antibody 10 ; Koenig
and Kunkel, 1990) also react with the fusion protein and with
the Torpedo 300-kD protein (data not presented) . Since the
isolatedcDNA is 4 .1 kb and hybridizes to RNA which is -14
kb in length (Fig . 7), the sequence encoded by the cDNA is
incomplete (seven additionalcDNAs from sequences further
5' have been isolated, see Materials and Methods) .
The amino acid sequence deduced from the 5' end of the
cDNA has 59 and 72% homology, respectively, with the
23rd and 24th repeat in human dystrophin (Koenig and
Kunkel, 1990 ; Davison and Critchley, 1988) . This same re-
peat region has more limited sequence homology with spec-
trins (ti20 %), a-actinin (28 %), and myosins (ti20% ) . More-
over, alignment of the sequences encoded by the Torpedo
cDNA and dystrophin requires no gaps, whereas alignment
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Figure S. The amino acid sequences of the Torpedo 300-kD subsynaptic protein and humandystrophin are similar. The nucleic acid and
aminoacid sequence ofthe protein coding portionof the 4.1 kb cDNA are illustrated in a. (b) Theprotein coding portion of the Torpedo
4.1-kb cDNA (TORDYS) is aligned with the humandystrophin (HUMDYS) sequence that extends from amino acid 2803 to the carboxy
terminus of the a isoform. Identical residues in the HUMDYS sequence are indicated with a dash (-) and amino acid substitutions are
shown by the one-letter amino acid notation. A gap in the TORDYS sequence, which is indicated with asterisks (*), aligns with amino
acids 3409-3421 in HUMDYS and signifies theb isoform of dystrophin; homology of the human dystrophin b isoformwith the Torpedo
300-kD protein, which is encoded by the partial cDNA, is 84%. The DNA sequence of the partial cDNA encoding the Torpedo 300-kD
protein is available from EMBL/GenBank/DDBJ under accession number M37645.
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AGTGGTGAGCAGTGGMWWCTGCACATCTCMMCAGGICTTC=GACGTWAT~TTTMACAACCATGAACTAAGFAGGCAAATGCMATTGGTWTFAMCTWMMGTCTGMAGCAGAACGATGTTCACCGAATTTTCMG 150
e q e q v k r 1 q i e 1 q d f 1 t v m n 1 k n d e 1 r r q n p 1 q q d a p t v c q q n d v h r 1 f k 50
CGAGAGTTGAIIGGCAMGGMCCAGTGGMATGAWMTTTGGMACAGTGCATTTGTTCTTGGCTGATMAGCMTCIIGAG=CCTGNUGTCTTTTMCTGGACCAAGAGAG7JUATACMMAGPGAACATCCAAMTMTGCGAAA 300
r e 1 k a k e p v v m a a 1 d t v h 1 f 1 a d p a i r a p e 9 1 1 t q p r e k 1 p e e n i q n v a k 100
CGCATTCGGMGTATGCCGAGCAWTGAAAGTGGAAMGGATAAGCTGAGCAATCG~~=TGATTGOCAGAAOCGTATAGATG06GGCCTTGMGGICT~WMTTGCAAGATTCAATGGATGMTTGMCCTCAAATTGAGACAG 450
r 1 r k y a a a v k v e v d k 1 e n r a v d v q k r 1 d e a 1 k r 1 1 e 1 q d a m d a 1 n 1 k 1 r q 150
GCTGMWTATCAAAGATACATGWMC~MCGWCATCTACTMTAGACTCATTWAGGITCAGTTCAAAAACTCMGGTTTTTCGAGCA~MWTMMTGMGGAAAAT=CACTMCATGMTGAMMWTTCCCAGTTC 600
a e a 1 k d t v q p v q d 1 1 1 d e 1 q d h 1 e k v k v f r a e i a p m k e n v t h m n d 1 a e q f 200
ACACCACCTGATAMCMTTAMCCCGTACMTCTAAACCAGTMGAWATCTG1ACACACGOTGGIMCTMMCA=WCTATAGATGAGCTTCMMCCAWTGMTGAGGCTMTAGGTTTTGCACCMMTCCMGCACTTC 750
t p P d 1 q 1 a p y n 1 n q 1 a d 1 n t r v k 1 1 q v a 1 d e 1 1 k q 1 h e a h r d f q p t e q h f 250
CTATCMCTTCTGTCCAAGGTMTTGGGMCGAGCMTATCACCCMCAAGGTTMCTACTACATTAACCACCAAACTGCACCACCIWTWGTCMMCAACATGACGGAGCTCTATCMMACTAGCCGATCTAMTMMTCMG 900
1 e t e v q q p v e r a 1 e p n k v p y y 1 n h q t q t t c v d h p k m t e 1 y q e 1 a d 1 n n v r 300Figure6 . The domain structure of dystrophin and the domain orga-
nization of the Torpedo300-kD protein are identical . The cartoon
illustrates the location ofthe amino terminal region (solidbox), the
repeat units (open boxes), the fourth hinge and cysteine-rich region
(stippled) and the carboxy-terminal region (hatched) in dystrophin
(Koenig and Kunkel, 1990) . The cartoon depicts the first two and
last two repeats in dystrophin . Parentheses illustrate the region of
the 300-kD protein that is not encoded by the cDNA. Homology
between human dystrophin and the Torpedo 300-kD protein is indi-
cated separately for each domain : 23rd repeat, amino acids
2803-2931 ; 24th repeat, 2932-3040 ; 4th hinge, 3041-3112 ;
cysteine-rich, 3113-3360 ; and carboxy-terminal, 3361-3685 (Koe-
nig and Kunkel, 1990 ; Koenig et al ., 1988) .
of either the Torpedo cDNA or dystrophin with spectrin re-
quires two single amino acid gaps within each repeat (Koenig
and Kunkel, 1990 ; Davison and Critchley, 1988) . Thus, the
region of sequence homology between the Torpedo cDNA
and human dystrophin includes a region of dystrophin that
is thought to be fundamental for establishing its tertiary
structure (Koenig and Kunkel, 1990 ; Davison and Critch-
ley, 1988) .
Since the dystrophin sequence that follows the repeat units
is unrelated to spectrin and vertebrate ci-actinin, comparison
within this region is a more stringent criterion for establish-
ing structural similarity to dystrophin (Koenig et al., 1988 ;
Feener et al ., 1989) . Fig . 6 shows that there is 97% homol-
ogy between the fourth hinge region of dystrophin and the
proline-rich sequence following the predicted 24th repeaten-
coded by the Torpedo cDNA . This degree of conservation
suggests that the fourth hinge region of dystrophin has a crit-
ical functional role, and that this domain has an importance
in addition to disruption of the alpha helical organization .
Moreover, beyond thehinge regionofdystrophinis a cysteine-
rich region followed by the carboxy-terminal region . Both of
these regions are conserved in the Torpedo cDNA (91 and
89% identity, respectively) . Thus, the sequence encoded by
the cDNA is highly homologous to dystrophin, and is only
distantly related to spectrin, ot-actinin, and myosin .
Since humans possess an autosomal gene that encodes a
protein, DRP, with homology to the product of the X-linked
dystrophin gene (the partial cDNA has 80% amino acid se-
quence identity with the dystrophin a isoform) (Love et al .,
1989), it seemed possible that the protein encoded by Torpe-
do cDNA could be the homologue of this autosomal gene,
rather than of dystrophin . However, alignment of the corre-
sponding sequence encoded by the Torpedo cDNA with the
protein product of this autosomal gene reveals 72% identity
in the region of overlap and requires several gaps, whereas
alignment with dystrophin shows 88% identity and requires
no gaps. Moreover, antibodies against mammalian dystrophin
(antibody 11 ; Koenig and Kunkel, 1990) react with the
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Torpedo 300-kD protein, but not with mammalian DRP
(Hoffman et al., 1989) . Thus, we think it likely that the pro-
tein encoded by the Torpedo cDNA is Torpedo dystrophin .
Multiple dystrophin transcripts, which are generated by
alternative splicing, yield several isoforms (Feener et al .,
1989) . The b isoform of dystrophin lacks 13 amino acids
present in the carboxy-terminal region of the a isoform and
is generated by splicing and removal of 39 nucleotides
(Feener et al ., 1989) . The Torpedo cDNA sequence illus-
trated in Fig . 5 corresponds to the b isoform, and this align-
ment supports further the conclusion that the protein en-
coded by the Torpedo cDNA is dystrophin . The b isoform,
however, is notthe only isoform present in the electric organ,
since we have isolated an electric organ cDNA that encodes
the a isoform of dystrophin (Ravin et al ., 1991) .
Discussion
Figure 7 . cDNA encoding the Torpedo 300-kD
protein hybridizes to a -14-kb RNA (arrow)
in Torpedo electric organ. The positions of 18S
and 28SrRNA are indicated with arrowheads .
The filter was exposed to x-ray film with an in-
tensifying screen for 3 d at -70°C .
This study demonstrates that a protein in Torpedo electric or-
gan is highly homologous tomammalian dystrophin . The ex-
tent ofsequence homology withmammalian dystrophin indi-
cates that this Torpedo protein is Torpedo dystrophin rather
than a dystrophin-related protein . Consistent with this in-
terpretation, antibodies against murine dystrophin, which do
not cross-react with murine DRP, react with the same 300-
kD electric organ protein that copurifies with AChR-rich
postsynaptic membranes, and a mAb (601) directed against
the electric organ 300-kD subsynaptic protein reacts with
synaptic and nonsynaptic membrane in normal, but not dys-
trophic mouse muscle.
We think it is likely that the protein encoded by the 4.1-kb
6DNA, which we designate Torpedo dystrophin, is the 300-
1074kD subsynaptic protein that we identified previously on the
basis of copurification with AChR-rich postsynaptic mem-
branes from Torpedo electric organ. First, the cDNA en-
codesa protein that reacts with a mAb (602) directed against
the electric organ 300-kD subsynaptic protein . Second, anti-
bodies against dystrophin (antibody 10; Koenig and Kunkel,
1990) react both with the fusion protein and with the Torpedo
300-kD protein (data not presented). These results support
the conclusion that the 300-kD subsynaptic protein which
copurifies with electric organ postsynaptic membranes is
Torpedo dystrophin.
Furthermore, we have screened our electric organ cDNA
library at moderate stringency with a probe derived from the
4.1-kb cDNA and isolated seven additional cDNAs that en-
code Torpedo dystrophin (see Materials and Methods) and
no cDNAs that encode a dystrophin-like protein. Thus, the
abundance ofdystrophin cDNAs in the electric organlibrary
is similar to the abundance of 300-kD protein in the electric
organ, and dystrophin-like sequences are likely to be present
at much lower abundance than dystrophin, if at all, in the
electric organ .
Recent studies have demonstrated that antibodies against
dystrophin cross-react with a Torpedo electric organ protein
of -400 kD that is enriched at the postsynaptic membrane
(Chang et al., 1989; Jasmin et al., 1990). Moreover, a recent
study showed that antibodies against murine dystrophin
cross-react with a protein at neuromuscular synapses in nor-
mal rat muscle, and that antibodies against the Torpedo 400-
kD protein react with nonsynaptic membrane in normal, but
not dystrophic, humanmuscle (Chang et al., 1989). Because
antibodies against dystrophincan cross-react with other pro-
teins that contain homologous domains, as described above,
and because these studies did not determine whether anti-
body staining was absent from synaptic sites in dystrophic
muscle, it is difficult to ascertain whether the cross-reacting
molecule at the synapse is dystrophin, rather than another
molecule that shares epitopes with dystrophin. Indeed, a re-
cent study demonstrated that some antibodies against dystro-
phin do react with synaptic sites in dystrophic muscle, and
these authors suggest that a dystrophin-related protein is
present at synaptic sitesin normal muscle and persists in dys-
trophic muscle (Fardeau et al., 1990; Pons et al., 1991) . Our
study demonstrates that there is extensive homology between
the amino acid sequences for mammalian dystrophin and the
Torpedo 300-kD subsynaptic protein, and that antibodies
against the Torpedo subsynaptic protein react with synaptic
sites in normal, but not dystrophic muscle. Thus, we con-
clude that dystrophin itself is present in the electric organ
and at synaptic sites in skeletal muscle.
In skeletal muscle dystrophin is found in the synaptic and
nonsynaptic myofiber membrane, but is more concentrated
at synaptic sites. It is unclear to what extent the increase in
membrane surface area at the synaptic site, due to postjunc-
tional folds, contributes to the higher dystrophin concentra-
tion observed by light microscopy (Woodruff et al., 1987;
Sealock et al., 1991), and immunoelectron microscopy will
be necessary to resolve this issue.
How does dystrophin associate with the postsynaptic
membrane and with the nonsynaptic membrane of skeletal
muscle fibers? We showed previously that postsynaptic
membranes isolated from Torpedo electric organ contain
stoichiometric quantities of AChR and the 43-kD subsynap-
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tic protein, and N10-fold lower levels of the 300-kD protein
(Burden et al ., 1983). We postulated that the 300-kD protein
could serve as a scaffold upon which multiple copies of the
43RD protein could associate, and that this assembly could
serve to stabilize the structure ofthe postsynaptic membrane
in the electric organ (Woodruffet al., 1987). One prediction
of this model was that the 300-kD protein would have a re-
peat unit structure upon which multiple copies of the 43-kD
protein could be arranged, and indeed the 300-kD protein
does have repeated structural units. Nevertheless, the repeat
units in the 300-kD protein may not be involved in targeting
the protein to the postsynaptic membrane, and the actin-
binding domain or the carboxy-terminal region may serve
this function. Further, there is evidence that a 58-kD sub-
synaptic protein associates with dystrophin, and this protein
could be important for membrane targeting (Sealock et al.,
1991). Nevertheless, because the AChR-rich postsynaptic
membrane from Torpedo electric organ contains largely the
four AChR subunits and two peripheral membrane proteins
of43 and 300 kD (Froehner, 1986; Burden, 1987), this strik-
ingly simple membrane should be aparticularly favorable sys-
tem to study how dystrophin becomes membrane-associated.
The distribution of dystrophin and AChR/43-kD protein is
less well correlated in skeletal muscle than in the electric or-
gan. First, dystrophin is present in the nonsynaptic mem-
brane of myofibers, where neither AChR nor 43-kD protein
are detectable. Second, the precise distribution ofdystrophin
and AChR within AChR-rich domains found in cultured em-
bryonic muscle cells and at synaptic sites can be distinct
(Sealock et al., 1991). Thus, proteins other than AChR/43-
kD must link dystrophin to nonsynaptic membrane (Ervasti
et al., 1990; Campbell and Kahl, 1989), and could link dys-
trophin to the synaptic membrane as well.
We do not know what function dystrophin has at the syn-
apse, norhow loss ofdystrophin from skeletal muscle results
in myopathies. Since AChRs are concentrated at synaptic
sitesin dystrophic muscle (Fig. 2), it seems clear that dystro-
phin is not required for the formation of AChR clusters. Be-
causedystrophin is a component of neuromuscular synapses
and is suitably positioned to have a role in stabilizing the
structure of the postsynaptic membrane, loss of dystrophin
may nevertheless have consequences for synaptic transmis-
sion. Indeed, electron microscopic studies of dystrophic
muscle have illustrated simplification ofthe synapse, notably
a reduction in the number ofpostjunctional folds (Jerusalem
et al., 1974; Torres and Duchen, 1987; Nagel et al., 1990).
However, these changes may reflect properties of degenerat-
ing or regenerating muscle and may only be an indirect con-
sequence of loss of dystrophin .
The presence of dystrophin in the electrocyte, a cell which
is specialized for synaptic transmission and does not con-
tract, suggests that dystrophin can have a role other than
stabilizing the plasma membrane from structural distortion
during contraction . Furthermore, the location of dystrophin
exclusively at the postsynaptic membrane of the electrocyte
suggests that dystrophies function in this cell is associated
with synaptic structure and/or function.
Current ideas for therapeutic treatment of patients with
muscular dystrophy include injections of normal myoblasts
into dystrophic muscle to promote formation of chimeric
myotubes containing normal nuclei. Since the synaptic re-
gion of a skeletal myofiber is <1% of the myofiber volume,
1075anddystrophin may notdiffuse freely in amyofiber, reconsti-
tution of synaptic dystrophin may require that normal nuclei
be situated in the synaptic region . If dystrophin has an im-
portant role at the synapse, successful therapeutic treatment
may requireasubstantial increase in the efficiency ofnormal
myoblast incorporation into chimeric myotubes.
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